Login / Signup

Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer.

Viktoria StühlerJan Moritz MaasJonas BochemInês Anselmo da CostaTilman TodenhöferArnulf StenzlJens Bedke
Published in: World journal of urology (2018)
Validated robust biomarkers are still needed to overcome this hurdle to forecast response of ICI in UC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • papillary thyroid
  • prognostic factors
  • high grade
  • squamous cell carcinoma
  • patient reported outcomes